Allogene Therapeutics (ALLO) Retained Earnings (2018 - 2026)
Allogene Therapeutics (ALLO) reported Retained Earnings of -$183000.0 for Q1 2026, up 99.99% on a YoY basis from -$91504.5 in Q1 2025, and up 99.99% sequentially from -$2.0 billion in Q4 2025.
Allogene Therapeutics (ALLO) Retained Earnings (2018 - 2026) Analysis & Trends
Allogene Therapeutics (ALLO) has 9 years of Retained Earnings data on file, last reported at -$183000.0 in Q1 2026.
- For the quarter ending Q1 2026, Retained Earnings rose 99.99% year-over-year to -$183000.0; the trailing twelve-month figure through Mar 2026 stood at -$183000.0 (up 99.99% YoY), and the FY2025 full-year result was -$2.0 billion, down 2259123.6% from the prior year.
- Retained Earnings improved to -$183000.0 in Q1 2026, from -$2.0 billion in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $157000.0 in Q3 2024 to a low of -$2.0 billion in Q4 2025.
- A 5-year average of -$949.9 million and a median of -$1.1 billion in 2022 frame the typical range for Retained Earnings.
- Across the five-year window, Retained Earnings surged 106.51% in 2024 and tumbled 2259123.6% in 2025, its largest moves.
- Tracing ALLO's Retained Earnings over 5 years: stood at -$9.9 million in 2022, then slumped by 15638.8% to -$1.6 billion in 2023, then surged by 99.99% to -$89000.0 in 2024, then plunged by 2259123.6% to -$2.0 billion in 2025, then soared by 99.99% to -$183000.0 in 2026.
- Business Quant data shows ALLO's Retained Earnings at -$183000.0 in Q1 2026, -$2.0 billion in Q4 2025, and -$2.0 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -27.89 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.91 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 115.82 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -622,000.00 |
| 10 | Allogene Therapeutics | 437.33 Mn | 437.33 Mn | - | -183,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -183,000.00 |
| Dec 31, 2025 | -2.01 Bn |
| Sep 30, 2025 | -1.97 Bn |
| Jun 30, 2025 | -1.93 Bn |
| Mar 31, 2025 | -1.88 Bn |
| Dec 31, 2024 | -89,000.00 |
| Sep 30, 2024 | 157,000.00 |
| Jun 30, 2024 | -1.69 Bn |
| Mar 31, 2024 | -1.63 Bn |
| Dec 31, 2023 | -1.56 Bn |
| Sep 30, 2023 | -2.41 Mn |
| Jun 30, 2023 | -1.41 Bn |
| Mar 31, 2023 | -5.93 Mn |
| Dec 31, 2022 | -9.93 Mn |
| Sep 30, 2022 | -12.96 Mn |
| Jun 30, 2022 | -1.05 Bn |
| Mar 31, 2022 | -973.16 Mn |
| Dec 31, 2021 | -2.57 Mn |
| Sep 30, 2021 | -398,000.00 |
| Jun 30, 2021 | -334,000.00 |